LLY:NYSE
Eli Lilly And Co
$1,168.62
arrow_upward
+0.37%(+4.30) 1D
Sep 22, 1:35:20 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LLY...
Open
$1,146.15
High
$1,180.53
Low
$1,139.26
Mkt. cap
1.10T
Avg. vol.
2.43M
Volume
1.19M
Dividend
0.59%
Quarterly dividend
$1.73
Ex-dividend date
Aug 14, 2026
P/E ratio
39.22
52-wk high
$1,292.65
52-wk low
$712.05
EPS
$29.80
Beta
0.50
Shares outstanding
941.36M
No. of employees
50K
Open
$1,146.15
High
$1,180.53
Low
$1,139.26
Mkt. cap
1.10T
Avg. vol.
2.43M
Volume
1.19M
Dividend
0.59%
Quarterly dividend
$1.73
Ex-dividend date
Aug 14, 2026
P/E ratio
39.22
52-wk high
$1,292.65
52-wk low
$712.05
EPS
$29.80
Beta
0.50
Shares outstanding
941.36M
No. of employees
50K
News stories
From web sources and news partners
TipRanks
·
52 minutes ago
Eli Lilly Completes Key Phase 1 Study of Remternetug in China: What Investors Should Watch Next
TipRanks
·
52 minutes ago
Eli Lilly’s New Obesity Candidate LY4329090: Early Trial Update and Investor Watchpoints
News Corp
·
59 minutes ago
Viking Therapeutics Stock Surges 32%. It Could Challenge Lilly and Novo’s Obesity Empire.
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Co
CEODavid A. Ricks | Yie-Hsin Hung
Employees50K
Founded1978
HeadquartersIndianapolis, Indiana, United States
SectorCapital market
Websitelilly.com